Infectious Diseases Department, Dron Hospital, Tourcoing, France.
Virology Laboratory, CHRU, Lille, France.
Sex Transm Infect. 2019 Feb;95(1):75-77. doi: 10.1136/sextrans-2017-053395. Epub 2018 Jun 9.
Since February 2017, an increase of acute hepatitis A (AHA) cases has been notified in North of France. We aimed to report clinical and virological features of 49 cases treated in three hospitals in Lille European Metropolis (LEM).
All adult patients treated for AHA in 3 LEM hospitals between 20 February and 5 July 2017 were included. Demographic characteristics, exposure risk factors to hepatitis A virus (HAV), AHA manifestations and concomitant sexually transmitted infections (STI) were retrospectively recorded.
Forty-nine cases of AHA were diagnosed among which 34 (69%) were hospitalised. Severe AHA occurred in 7 (14%) patients. The median age of cases was 36 years. All cases except 1 were men and 32 (65%) were identified as men having sex with men (MSM). Eleven (23%) patients were HIV-infected, 5 were under HIV pre-exposure prophylaxis (PrEP), 6 had a history of HIV postexposure prophylaxis and 19 had a history of at least one STI. Only three patients had received HAV vaccine. Proportion of patients tested for syphilis, chlamydial and gonococcal infections was 75% (18/24) in those seen by sexual health specialists and 21% (6/29) in those seen by other specialists. At least one concomitant STI was diagnosed in 13 out of 24 tested patients (54%). RT-PCR sequencing was available for 38 cases and confirmed co-circulation of 3 different strains of subgenotype IA (VRD 521 2016: n=24, RIVM-HAV16-090: n=13, V16-25801: n=1), already identified in several European countries.
We are facing an outbreak of AHA among MSM in the North of France with a high rate of hospitalisation. Analysis of cases highlighted missed opportunities of vaccination and lack of concomitant STI screening. Awareness among healthcare providers and MSM should be increased and HAV vaccination promoted.
自 2017 年 2 月以来,法国北部已报告多例急性甲型肝炎(AHA)病例。我们旨在报告在里尔欧洲都会区(LEM)的 3 家医院接受治疗的 49 例病例的临床和病毒学特征。
2017 年 2 月 20 日至 7 月 5 日期间,在里尔欧洲都会区的 3 家医院接受 AHA 治疗的所有成年患者均被纳入本研究。回顾性记录人口统计学特征、甲型肝炎病毒(HAV)暴露危险因素、AHA 表现和同时发生的性传播感染(STI)。
在诊断出的 49 例 AHA 患者中,有 34 例(69%)住院。7 例(14%)患者出现严重 AHA。病例的中位年龄为 36 岁。除 1 例外,所有病例均为男性,其中 32 例(65%)为男男性行为者(MSM)。11 例(23%)患者感染 HIV,5 例正在接受 HIV 暴露前预防(PrEP),6 例有 HIV 暴露后预防史,19 例有至少一种 STI 史。只有 3 例患者接种过 HAV 疫苗。在接受性健康专家检查的 24 例患者中,75%(18/24)检测了梅毒、衣原体和淋病感染,而在接受其他专家检查的 29 例患者中,21%(6/29)检测了这些感染。在接受检测的 24 例患者中,有 13 例(54%)至少诊断出一种同时发生的 STI。对 38 例病例进行了 RT-PCR 测序,证实了亚基因型 IA 的 3 种不同株(VRD5212016:n=24、RIVM-HAV16-090:n=13、V16-25801:n=1)的共同循环,这些株已经在欧洲多个国家被发现。
我们正在法国北部面临一场 MSM 中的 AHA 爆发,住院率很高。对病例的分析突出了疫苗接种和缺乏同时发生的 STI 筛查的机会。应该提高医疗保健提供者和 MSM 的认识,并推广 HAV 疫苗接种。